Delivery Order SPE2DB20D1004-SPE2DB21FF8Z1
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $36,734.87 Firm Fixed Price Delivery Order contract is for the supply of Topamax 25 mg sprinkle capsules. The award has an ultimate completion date of December 20, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,561,784,974 units of Topamax 25 mg sprinkle capsules. The $1,445.50 firm fixed-price delivery order has an ultimate completion date of August 14, 2023. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does...
- This federal contract award, with ID SPE2DB20D1051/SPE2DB24FD6XV, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,924.68 firm fixed-price delivery order is for the supply of TOPAMAX 25 MG SPRINKLE CAP 60S, a pharmaceutical product. The award has an ultimate completion date of February 6, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up...
- This federal contract award, with ID SPE2DB20D3101|SPE2DB23FQZT7, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,469.20 delivery order is for the supply of Topamax 25 mg sprinkle capsules. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This $999,999,999 IDC serves as the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,580.08 firm fixed price delivery order is for the supply of Topamax 25 mg sprinkle capsules. The award is associated with a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. (doing business as Amerisourcebergen) and the DLA Troop Support Medical, valued at up to $999,999,999.00 through November...
- This federal contract award, valued at $5,432.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 60 units of the drug Topamax 25 mg sprinkle capsules. The contract has a firm fixed price pricing type and an ultimate completion date of December 11, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,828.80 firm-fixed-price delivery order is for the supply of Topamax 25 mg sprinkle capsules. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,521.47, is for the delivery of Topamax 25 mg sprinkle capsules. It is a firm-fixed-price delivery order contract type with a completion date of February 13, 2024. The contract is not designated as a set-aside, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of Cencora,...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,518.04, is a delivery order for the supply of Topiramate (Topamax) 25 mg sprinkle capsules. The contract has an ultimate completion date of January 11, 2024 and is a firm fixed-price contract. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite...
- This federal contract award SPE2DX15D3005|SPE2DX24F3MXM, valued at $3,860.65, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award is for the provision of 4562842053 - TOPAMAX 25 MG SPRINKLE CAP 60S, a pharmaceutical product. The contract has an ultimate completion date of November 17, 2023 and is a Firm Fixed Price Delivery Order. Amerisourcebergen Drug Corp, a major pharmaceutical...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB21FF8Z1Delivery Order
This federal contract award, identified as SPE2DB20D1004|SPE2DB21FF8Z1, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $1,934.26, is for the delivery of the pharmaceutical product Topamax 15 mg sprinkle capsules. The contract is a delivery order, with a firm fixed price pricing type, and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veterans' healthcare programs globally. Additionally, Cencora, Inc. maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000, for similar medical products and prescription drugs. These IDCs demonstrate the company's capacity to meet the diverse pharmaceutical needs of multiple government agencies on a large scale.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 8/2/21 |